MSN Ecuador represents a strong commitment to innovation and continuous improvement in the healthcare sector. Backed by MSN’s global strength of 17 API manufacturing plants, 8 finished dosage facilities, and an integrated Research & Development Center, we deliver high-quality, safe, reliable, and affordable pharmaceutical solutions.
Our focus is on enhancing patient access, improving therapeutic adherence, and ensuring safety through awareness initiatives, pharmacovigilance systems, and strong partnerships with patient groups.
With a research-driven approach, MSN Ecuador supports stakeholders in successfully launching quality pharmaceutical products while building long-term commercial synergies and strategic collaborations.
Integrated research approach supporting innovation and quality.
Backed by world-class manufacturing and global presence.
Improving access, adherence, and safety across therapies.
Our Quito branch has successfully launched pharmaceutical products that have become category leaders in the market.
Our vision is to strengthen MSN Labs’ presence in Ecuador by expanding our portfolio, enhancing commercial synergies, and exploring strategic licensing partnerships.
We aim to continue supporting stakeholders with innovative, research-backed pharmaceutical solutions.
For requests, adverse event reports, technical complaints, or medical information:
MSN Labs Ecuador SA
Guayas E3-112 y Amazonas,
Edificio Torre Centre,
Piso 5, Oficina 501
We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.